• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    NKGen Biotech, Inc. - Common Stock (NQ: NKGN )

    1.170 -0.110 (-8.59%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 23, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 961,757
    Open 1.300
    Bid (Size) 1.160 (3)
    Ask (Size) 1.170 (16)
    Prev. Close 1.280
    Today's Range 1.120 - 1.364
    52wk Range 0.7802 - 6.700
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Why Tellurian Shares Are Trading Higher By Around 65%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Why Domino's Pizza Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga

    Performance

    YTD
    -61.39%
    -61.39%
    1 Month
    -1.68%
    -1.68%
    3 Month
    -36.76%
    -36.76%
    6 Month
    -55.34%
    -55.34%
    1 Year
    -79.51%
    -79.51%

    More News

    Read More
    Barclays Just Raised Its Price Target on Intuitive Surgical (ISRG) Stock
    Via InvestorPlace
    NKGN Stock Earnings: NKGen Biotech Reported Results for Q1 2024
    Via InvestorPlace
    WBD Stock Pops as Warner Bros. Considers Streaming Spinoff
    Via InvestorPlace
    Why Is NKGen Biotech (NKGN) Stock Up 18% Today?
    Via InvestorPlace
    Why NKGen Biotech (NKGN) Stock Is Skyrocketing
    Via Benzinga
    NKGen Biotech to Present New Positive SNK01 Clinical Trial Biomarker Data at the 2024 Alzheimer’s Association International Conference
    From NKGen Biotech
    Via GlobeNewswire
    NKGen Biotech Appoints Dr. Marco Gottardis to its Board of Directors
    From NKGen Biotech
    Via GlobeNewswire
    NKGen Biotech Presents Updated Phase 1 Data on SNK02 Allogeneic NK Cell Therapy for Solid Tumors at the 6th Annual Allogeneic Cell Therapies Summit 2024
    From NKGen Biotech
    Via GlobeNewswire
    Spotlighting Unexplored Stocks in Focus: NKGN, INBS, BTBT, PRSO, MGOL
    Via AB Newswire
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Dow Falls Over 150 Points; Sohu Posts Q1 Loss
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Virios Therapeutics Shares Are Trading Lower By Around 48%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Nasdaq Surges 100 Points; Wix.com Shares Jump Following Q1 Results
    Via Benzinga
    NKGN Stock Alert: The Alzheimer’s News That Has NKGen Biotech Soaring Today
    Via InvestorPlace
    Why NKGen Biotech Stock Is Moving Higher Monday
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    What's Going On With Nano-Cap NKGen Biotech Stock On Monday?
    Via Benzinga
    Why Vaxxinity Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.